KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beyond Meat (BYND) Total Liabilities (2018 - 2025)

Beyond Meat has reported Total Liabilities over the past 8 years, most recently at $615.7 million for Q4 2025.

  • Quarterly results put Total Liabilities at $615.7 million for Q4 2025, down 51.87% from a year ago — trailing twelve months through Dec 2025 was $615.7 million (down 51.87% YoY), and the annual figure for FY2025 was $615.7 million, down 51.87%.
  • Total Liabilities for Q4 2025 was $615.7 million at Beyond Meat, down from $1.4 billion in the prior quarter.
  • Over the last five years, Total Liabilities for BYND hit a ceiling of $1.4 billion in Q3 2025 and a floor of $615.7 million in Q4 2025.
  • Median Total Liabilities over the past 5 years was $1.3 billion (2023), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Total Liabilities: skyrocketed 1135.67% in 2021 and later tumbled 51.87% in 2025.
  • Beyond Meat's Total Liabilities stood at $1.2 billion in 2021, then grew by 1.51% to $1.3 billion in 2022, then grew by 1.74% to $1.3 billion in 2023, then decreased by 0.66% to $1.3 billion in 2024, then tumbled by 51.87% to $615.7 million in 2025.
  • The last three reported values for Total Liabilities were $615.7 million (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.